Efficacy of Radioembolization According to Tumor Morphology and Portal Vein Thrombosis in Intermediate–Advanced Hepatocellular Carcinoma
Author(s) -
Rita Golfieri,
Cristina Mosconi,
Alberta Cappelli,
Emanuela Giampalma,
Maria Cristina Galaverni,
Cinzia Pettinato,
Matteo Renzulli,
Fabio Monari,
Bruna Angelelli,
Patrizia Pini,
Eleonora Terzi,
Salvatore Ascanio,
Giorgio Garzillo,
Fabio Piscaglia,
Luigi Bolondi,
Franco Trevisani
Publication year - 2015
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon.15.267
Subject(s) - medicine , hepatocellular carcinoma , portal vein thrombosis , radiology , thrombosis , portal vein
Purpose: We analyzed overall survival (OS) following radioembolization according to macroscopic growth pattern (nodular vs infiltrative) and vascular invasion in intermediate–advanced hepatocellular carcinoma (HCC). Methods: Between September 2005 and November 2013, 104 patients (50.0% portal vein thrombosis [PVT], 29.8% infiltrative morphology) were treated. Results: Median OS differed significantly between patients with segmental and lobar or main PVT (p = 0.031), but was 17 months in both those with patent vessels and segmental PVT. Median OS did not differ for infiltrative and nodular HCC. Median OS was prolonged in patients with a treatment response at 3 months (p = 0.023). Prior TACE was also a significant predictor of improved OS. Conclusion: A further indication for radioembolization might be infiltrative HCC, since OS was similar to nodular types.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom